Showing 201-210 of 328 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| mIL-2/CD25 fusion protein and BTK inhibitor combination therapy for T1D | University of Miami | Wasif Khan | Cures | 01-May-2023 to 30-April-2026 | $974.996,00 |
| Newly identified novel autoantibodies specific to β-cell surface ZnT8 antigen as an early biomarker in type 1 diabetes | Regents of the University of Colorado | Xiaofan Jia | Cures | 01-September-2023 to 28-February-2026 | $499.998,96 |
| Defining human T cell-myeloid cell interactions in the islets | Regents of the University of Colorado | Rachel Friedman | Cures | 01-March-2023 to 28-February-2026 | $110.000,00 |
| Validation of a Tolerogenic Nanotherapy for Islet Transplantation in a Non-Human Primate Model | Northwestern University | Jacqueline Burke | Cures | 01-July-2023 to 30-June-2026 | $998.275,64 |
| Defining the Antigenic Landscape of Islet-Infiltrating T cells in Type 1 Diabetes | University of Pittsburgh | Alok Joglekar | Cures | 01-March-2023 to 28-February-2026 | $900.000,00 |
| MRI of Pancreas Perfusion in Response to Glucose | University of Texas at Austin | Jack Virostko | Cures | 01-July-2023 to 30-June-2025 | $187.620,00 |
| Cellular Sentinels of Islet Transplant Rejection | California Institute of Technology | Mikhail Shapiro | Cures | 01-July-2023 to 30-June-2026 | $750.000,00 |
| Multiplex in vivo imaging of the dynamics of immune-mediated rejection of allogenic islet grafts | The Regents of the University of California, Los Angeles | Oluwatayo Ikotun | Cures | 01-February-2024 to 31-January-2027 | $749.996,25 |
| Targeting Prostaglandin F-series Lipids to Counter Beta-Cell-Death and T1D Development | The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham | Sasanka Ramanadham | Cures | 01-May-2023 to 30-April-2026 | $749.763,00 |
| IL-37-EXPRESSING TREG CELLS TO IMPROVE T1D THERAPEUTIC STRATEGY | Regents of the University of Colorado | Mayumi Fujita | Cures | 01-March-2023 to 28-February-2026 | $750.000,00 |